Skip to main content
Signal8

LENSAR, Inc. (LNSR)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

LENSAR Inc logo

LENSAR Inc

NASDAQ:LNSRHealthcare
-2.18%$5.84
AH$5.84+0.00%vs close
Mkt Cap$71.75M
Float9.03M
O/S12.29M
Vol
$ Vol
RVOL
Inst Own35.8%
SI3.4%
Earnings
Dilution
FormDescription
10-Q
8-K
8-K
5.07
13G/A
Beneficial Ownership Report (Amended)
DEFA14A
Additional Proxy Materials
ARS
SEC Filing
DEF 14A
Definitive Proxy Statement
1
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
3
Initial Statement of Beneficial Ownership
S-8
SEC Filing
8-K
13G/A
Beneficial Ownership Report (Amended)
144
Notice of Proposed Sale of Securities
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership

1-25 of 327

…